SIMCERE PHARMACEUTICAL GROUP Finite-Lived Intangible Asset, Expected Amortization, Year Four

SIMCERE PHARMACEUTICAL GROUP Finite-Lived Intangible Asset, Expected Amortization, Year Four

SIMCERE PHARMACEUTICAL GROUP had Finite-Lived Intangible Asset, Expected Amortization, Year Four of CNY 28.14 million as of 2012-12-31, per its 20-F filed 2013-04-26.

Discontinued › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour · last filed 2013-04-26

• 2012-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Four 28.14M CNY.